AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-91
Results: 26-50/91

Authors: WALKER RE SPOONER KM KELLY G MCCLOSKEY V WOODY JN FALLOON J BASELER M PISCITELLI SC DAVEY RT POLIS MA KOVACS JA MASUR H LANE HC
Citation: Re. Walker et al., INHIBITION OF IMMUNOREACTIVE TUMOR-NECROSIS-FACTOR-ALPHA BY A CHIMERIC ANTIBODY IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, The Journal of infectious diseases, 174(1), 1996, pp. 63-68

Authors: KOVACS JA BECHTEL C DAVEY RT FALLOON J POLIS MA WALKER RE METCALF JA DAVEY V PISCITELLI SC BASELER M DEWAR R SALZMAN NP MASUR H LANE HC
Citation: Ja. Kovacs et al., COMBINATION THERAPY WITH DIDANOSINE AND INTERFERON-ALPHA IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS - RESULTS OF A PHASE I II TRIAL/, The Journal of infectious diseases, 173(4), 1996, pp. 840-848

Authors: KAIMANOVICH VA MASUR H
Citation: Va. Kaimanovich et H. Masur, THE POISSON BOUNDARY OF THE MAPPING CLASS GROUP, Inventiones Mathematicae, 125(2), 1996, pp. 221-264

Authors: MASUR H WHITCUP SM CARTWRIGHT C POLIS M NUSSENBLATT R
Citation: H. Masur et al., ADVANCES IN THE MANAGEMENT OF AIDS-RELATED CYTOMEGALOVIRUS RETINITIS, Annals of internal medicine, 125(2), 1996, pp. 126-136

Authors: MASUR H SHELHAMER JH
Citation: H. Masur et Jh. Shelhamer, OUTPATIENT MANAGEMENT OF HIV-RELATED PNEUMONIA - IN RESPONSE, Annals of internal medicine, 125(11), 1996, pp. 938-939

Authors: SHELHAMER JH GILL VJ QUINN TC CRAWFORD SW KOVACS JA MASUR H OGNIBENE FP
Citation: Jh. Shelhamer et al., THE LABORATORY EVALUATION OF OPPORTUNISTIC PULMONARY INFECTIONS, Annals of internal medicine, 124(6), 1996, pp. 585-599

Authors: MASUR H SHELHAMER J
Citation: H. Masur et J. Shelhamer, EMPIRIC OUTPATIENT MANAGEMENT OF HIV-RELATED PNEUMONIA - ECONOMICAL OR UNWISE, Annals of internal medicine, 124(4), 1996, pp. 451-453

Authors: KAPLAN JE HU DJ HOLMES KK JAFFE HW MASUR H DECOCK KM
Citation: Je. Kaplan et al., PREVENTING OPPORTUNISTIC INFECTIONS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PERSONS - IMPLICATIONS FOR THE DEVELOPING-WORLD, The American journal of tropical medicine and hygiene, 55(1), 1996, pp. 1-11

Authors: SCHAEFFER MH KRANTZ DS WICHMAN A MASUR H REED E VINICKY JK
Citation: Mh. Schaeffer et al., THE IMPACT OF DISEASE SEVERITY ON THE INFORMED CONSENT PROCESS IN CLINICAL RESEARCH, The American journal of medicine, 100(3), 1996, pp. 261-268

Authors: KAPLAN JE MASUR H HOLMES KK
Citation: Je. Kaplan et al., USPHS AND IDSA COLLABORATE ON GUIDELINES TO PREVENT OPPORTUNISTIC INFECTIONS IN HIV-INFECTED PERSONS, EMERGING INFECTIOUS DISEASES, 1(3), 1995, pp. 102-103

Authors: MASUR H
Citation: H. Masur, ALGORITHMIC APPROACH TO TREATMENT, Bailliere's clinical infectious diseases, 2(3), 1995, pp. 531-549

Authors: KAPLAN JE MASUR H HOLMES KK MCNEIL MM SCHONBERGER LB NAVIN TR HANSON DL GROSS PA JAFFE HW LANIER D SCHRAM N COOPER E FREEDBERG KA MAYER K BLINKHORN R ELLNER J ANGULO F BERKELMAN R BREIMAN R BRYAN R BUEHLER J CLADWELL B CASTRO K CHILDS JE CHU S CIESIELSKI C DROTMAN DP EDLIN B ELLERBROCK T FLEMING P GEITER L HAJJEH R HANSON D HOLMBERG S HUGHES J JAFFE H JONES J JURANEK D KAPLAN JE KELLER D MARTONE W MILLER B NAVIN T NESLUND V OSTROFF S PELLETT PE PINNER R REEF S REEVES WC REGNERY R RICHARDS F ROGERS M SIMONDS RJ SIMONE P SMITH D SOLOMON S SPIEGEL R STEWART J SWERDLOW D VERNON S WARD J NEAL J SCHLECH W WILFERT C HORSBURGH R MCGOWAN J RIMLAND D GOLDBERGER M TRAPNELL CB BARR D TORRES G STETLER H GROSS P ELSADAR W COTTON D GREAVES W BARTLETT J CHAISSON R FEINBERG J QUINN T HORMAN J MACDONALD K WILSON M SPERLING R AVANDANO A BAKER AC KALICA A KOVACS J POLIS M SCHNITTMAN S NELSON C PHAIR J BENSON C WOOD B HUGHES W LUFT B HYSLOP N WHITLEY R AMPEL N DREW WL KOEHLER J WOFSY C
Citation: Je. Kaplan et al., USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - INTRODUCTION/, Clinical infectious diseases, 21, 1995, pp. 1-11

Authors: KAPLAN JE MASUR H HOLMES KK WILFERT CM SPERLING R BAKER SA TRAPNELL CB FREEDBERG KA COTTON D POWDERLY WG JAFFE HW LANIER D SCHRAM N COOPER E MAYER K BLINKHORN R ELLNER J ANGULO J BERKELMAN R BREIMAN R BRYAN R BEUHLER J CALDWELL B CASTRO K CHILDS JE CHU S CIESIELSKI C DROTMAN DP EDLIN B ELLERBROCK T FLEMING P GEITER L HAJJEH R HANSON D HOLMBERG S HUGHES J JAFFE H JONES J JURANEK D KELLER D MARTONE W MCNEIL MM MILLER B NAVIN T NESLUND V OSTROFF S PELLETT PE PINNER R REEF S REEVES WC REGNERY R RICHARDS F ROGERS M SCHONBERGER LB SIMONDS RJ SIMONE P SMITH D SOLOMON S SPIEGEL R STEWART J SWERDLOW D VERNON S WARD J NEAL J SCHLECH W WILFERT C HORSBURGH R MCGOWAN J RIMLAND D GOLDBERGER M BARR D TORRES G STETLER H GROSS P ELSADR W GREAVES W BARTLETT J CHAISON R FEINBERG J QUINN T HORMAN J MACDONALD K WILSON M AVANDANO A BAKER AC KALICA A KOVACS J POLIS M SCHNITTMAN S NELSON C PHAIR J BENSON C WOOD B HUGHES W LUFT B HYSLOP N WHITLEY R AMPEL N DREW WL KOEHLER J WOFSY C
Citation: Je. Kaplan et al., USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - AN OVERVIEW/, Clinical infectious diseases, 21, 1995, pp. 12-31

Authors: KAPLAN JE MASUR H HOLMES KK LANIER D SCHRAM N COOPER E FREEDBERG KA MAYER K BLINKHORN R ELLNER J ANGULO F BERKELMAN R BREIMAN R BRYAN R BUEHLER J CALDWELL B CASTRO K CHILDS JE CHU S CIESIELSKI C DROTMAN DP EDLIN B ELLERBROCK T FLEMING P GEITER L HAJJEH R HANSON D HOLMBERG S HUGHES J JAFFE H JONES J JURANEK D KELLER D MARTONE W MCNEIL MM MILLER B NAVIN T NESLUND V OSTROFF S PELLETT PE PINNER R REEF S REEVES WC REGNERY R RICHARDS F ROGERS M SCHONBERGER LB SIMONDS RJ SIMONE P SMITH D SOLOMON S SPIEGEL R STEWART J SWERDLOW D VERNON S WARD J NEAL J SCHLECH W WILFERT C HORSBURGH R MCGOWAN J RIMLAND D GOLDBERGER M TRAPNELL CB BARR D TORRES G STETLER H GROSS P ELSADR W COTTON D GREAVES W BARTLETT J CHAISSON R FEINBERG J QUINN T HORMAN J MACDONALD K WILSON M SPERLING R AVANDANO A BAKER AC KALICA A KOVACS J POLIS M SCHNITTMAN S NELSON C PHAIR J BENSON C WOOD B HUGHES W LUFT B HYSLOP N WHITLEY R AMPEL N DREW WL KOEHLER J WOFSY C
Citation: Je. Kaplan et al., USPHS IDSA GUIDELINES FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS - DISEASE-SPECIFIC RECOMMENDATIONS/, Clinical infectious diseases, 21, 1995, pp. 32-43

Authors: PHAIR JP GROSS PA KAPLAN JE MASUR H HOLMES KK WILFERT CM
Citation: Jp. Phair et al., QUALITY STANDARDS FOR PREVENTING OPPORTUNISTIC INFECTIONS RELATED TO HUMAN-IMMUNODEFICIENCY-VIRUS AND THEIR IMPLEMENTATION, Clinical infectious diseases, 21, 1995, pp. 125-125

Authors: GROSS PA PHAIR JP KAPLAN JE HOLMES KK MASUR H
Citation: Pa. Gross et al., QUALITY STANDARD FOR THE ENUMERATION OF CD4(-IMMUNODEFICIENCY-VIRUS()LYMPHOCYTES IN ADULTS AND ADOLESCENTS INFECTED WITH HUMAN), Clinical infectious diseases, 21, 1995, pp. 126-127

Authors: PHAIR JP MASUR H GROSS PA HOLMES KK KAPLAN JE
Citation: Jp. Phair et al., QUALITY STANDARD FOR THE PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA IN ADULTS AND ADOLESCENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 21, 1995, pp. 128-129

Authors: PHAIR JP GROSS PA KAPLAN JE MASUR H HOLMES KK WILFERT CM MARTONE WJ CASTRO KG
Citation: Jp. Phair et al., QUALITY STANDARD FOR THE IDENTIFICATION AND TREATMENT OF PERSONS COINFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS AND MYCOBACTERIUM-TUBERCULOSIS, Clinical infectious diseases, 21, 1995, pp. 130-131

Authors: WILFERT CM MASUR H GROSS PA KAPLAN JE HOLMES KK PHAIR JP SIMONDS RJ
Citation: Cm. Wilfert et al., QUALITY STANDARD FOR THE PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA IN INFANTS AND CHILDREN BORN TO WOMEN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 21, 1995, pp. 132-133

Authors: WILFERT CM GROSS PA KAPLAN JE HOLMES KK MASUR H PHAIR JP SIMONDS RJ
Citation: Cm. Wilfert et al., QUALITY STANDARD FOR THE ENUMERATION OF CD4(-IMMUNODEFICIENCY-VIRUS()LYMPHOCYTES IN INFANTS AND CHILDREN EXPOSED TO OR INFECTED WITH HUMAN), Clinical infectious diseases, 21, 1995, pp. 134-135

Authors: WILFERT CM KAPLAN JE GROSS PA MASUR H HOLMES KK PHAIR JP
Citation: Cm. Wilfert et al., QUALITY STANDARD FOR THE IMMUNIZATION OF INFANTS AND CHILDREN BORN TOWOMEN INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 21, 1995, pp. 136-137

Authors: GROSS PA KAPLAN JE PHAIR JP MASUR H WILFERT CM HOLMES KK
Citation: Pa. Gross et al., INDICATORS FOR ASSESSMENT OF COMPLIANCE WITH QUALITY STANDARDS FOR THE PREVENTION OF OPPORTUNISTIC INFECTIONS IN PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 21, 1995, pp. 138-141

Authors: SPOONER KM LANE HC MASUR H
Citation: Km. Spooner et al., ANTIRETROVIRAL THERAPY - REFERENCE GUIDE TO MAJOR CLINICAL-TRIALS IN PATIENTS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, Clinical infectious diseases, 20(5), 1995, pp. 1145-1151

Authors: WALKER RE CARTER CS MUUL L NATARAJAN V HERPIN BR LEITMAN SF KLEIN HG FALLOON J DAVEY RT KOVACS JA POLIS MA MASUR H BLAESE RM LANE HC
Citation: Re. Walker et al., SURVIVAL AND DISTRIBUTION OF GENETICALLY-MODIFIED CELLS IN IDENTICAL-TWINS DISCORDANT FOR HIV-1 INFECTION, AIDS research and human retroviruses, 11, 1995, pp. 166-166

Authors: HOLSHOUSER BA KOMU M MOLLER HE ZIJLMANS T KOLEM H HINSHAW DB SONNINEN P VERMATHEN P HEERSCHAP A MASUR H RINNE UK DEKOSTER A TOSK JM
Citation: Ba. Holshouser et al., LOCALIZED PROTON NMR-SPECTROSCOPY IN THE STRIATUM OF PATIENTS WITH IDIOPATHIC PARKINSONS-DISEASE - A MULTICENTER PILOT-STUDY, Magnetic resonance in medicine, 33(5), 1995, pp. 589-594
Risultati: 1-25 | 26-50 | 51-75 | 76-91